Pretreatment Out-of-Pocket Expenses for Presumptive Multidrug-Resistant Tuberculosis Patients, India, 2016-2017

Priya Rathi; Kalpita Shringarpure; Bhaskaran Unnikrishnan; Vineet Kumar Chadha; Vishak Acharya; Abirami Nair; Karuna D. Sagili; Suresh Shastri

doi:10.3201/eid2605.181992

Pretreatment Out-of-Pocket Expenses for Presumptive Multidrug-Resistant Tuberculosis Patients, India, 2016-2017

Priya Rathi, Kalpita Shringarpure, Bhaskaran Unnikrishnan, Vineet Kumar Chadha, Vishak Acharya, Abirami Nair, Karuna D. Sagili, Suresh Shastri

Research output: Contribution to journal › Article

Abstract

In India, under the National Tuberculosis Elimination Programme, the government provides free treatment for multidrug-resistant tuberculosis; however, many patients seek care elsewhere, which is costly. To determine those out-of-pocket expenses, we interviewed 40 presumptive patients and found that they spent more than their median annual income before registering for the government program.

Original language	English
Pages (from-to)	989-992
Number of pages	4
Journal	Emerging Infectious Diseases
Volume	26
Issue number	5
DOIs	https://doi.org/10.3201/eid2605.181992
Publication status	Published - 01-05-2020

Fingerprint

All Science Journal Classification (ASJC) codes

Epidemiology
Microbiology (medical)
Infectious Diseases

Cite this

Rathi, P., Shringarpure, K., Unnikrishnan, B., Chadha, V. K., Acharya, V., Nair, A., Sagili, K. D., & Shastri, S. (2020). Pretreatment Out-of-Pocket Expenses for Presumptive Multidrug-Resistant Tuberculosis Patients, India, 2016-2017. Emerging Infectious Diseases, 26(5), 989-992. https://doi.org/10.3201/eid2605.181992

@article{45bd8057d9394e259122e0660d38d9f0,

title = "Pretreatment Out-of-Pocket Expenses for Presumptive Multidrug-Resistant Tuberculosis Patients, India, 2016-2017",

abstract = "In India, under the National Tuberculosis Elimination Programme, the government provides free treatment for multidrug-resistant tuberculosis; however, many patients seek care elsewhere, which is costly. To determine those out-of-pocket expenses, we interviewed 40 presumptive patients and found that they spent more than their median annual income before registering for the government program.",

author = "Priya Rathi and Kalpita Shringarpure and Bhaskaran Unnikrishnan and Chadha, {Vineet Kumar} and Vishak Acharya and Abirami Nair and Sagili, {Karuna D.} and Suresh Shastri",

year = "2020",

month = may,

day = "1",

doi = "10.3201/eid2605.181992",

language = "English",

volume = "26",

pages = "989--992",

journal = "Emerging Infectious Diseases",

issn = "1080-6040",

publisher = "Centers for Disease Control and Prevention (CDC)",

number = "5",

}

Pretreatment Out-of-Pocket Expenses for Presumptive Multidrug-Resistant Tuberculosis Patients, India, 2016-2017. / Rathi, Priya; Shringarpure, Kalpita; Unnikrishnan, Bhaskaran; Chadha, Vineet Kumar; Acharya, Vishak; Nair, Abirami; Sagili, Karuna D.; Shastri, Suresh.

In: Emerging Infectious Diseases, Vol. 26, No. 5, 01.05.2020, p. 989-992.

Research output: Contribution to journal › Article

TY - JOUR

T1 - Pretreatment Out-of-Pocket Expenses for Presumptive Multidrug-Resistant Tuberculosis Patients, India, 2016-2017

AU - Rathi, Priya

AU - Shringarpure, Kalpita

AU - Unnikrishnan, Bhaskaran

AU - Chadha, Vineet Kumar

AU - Acharya, Vishak

AU - Nair, Abirami

AU - Sagili, Karuna D.

AU - Shastri, Suresh

PY - 2020/5/1

Y1 - 2020/5/1

N2 - In India, under the National Tuberculosis Elimination Programme, the government provides free treatment for multidrug-resistant tuberculosis; however, many patients seek care elsewhere, which is costly. To determine those out-of-pocket expenses, we interviewed 40 presumptive patients and found that they spent more than their median annual income before registering for the government program.

AB - In India, under the National Tuberculosis Elimination Programme, the government provides free treatment for multidrug-resistant tuberculosis; however, many patients seek care elsewhere, which is costly. To determine those out-of-pocket expenses, we interviewed 40 presumptive patients and found that they spent more than their median annual income before registering for the government program.

UR - http://www.scopus.com/inward/record.url?scp=85083914578&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85083914578&partnerID=8YFLogxK

U2 - 10.3201/eid2605.181992

DO - 10.3201/eid2605.181992

M3 - Article

C2 - 32310069

AN - SCOPUS:85083914578

VL - 26

SP - 989

EP - 992

JO - Emerging Infectious Diseases

JF - Emerging Infectious Diseases

SN - 1080-6040

IS - 5

ER -

Access to Document

10.3201/eid2605.181992